Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-26 Sale | 2024-06-28 8:01 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 24,610 | $2.05 | $50,450 | 1,939,280 (Direct) | View |
| 2024-02-28 Sale | 2024-03-01 8:31 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 5,894 | $2.06 | $12,142 | 341,780 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 8:10 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 11,900 | $2.01 | $23,919 | 356,730 (Direct) | View |
| 2023-02-27 Sale | 2023-03-03 8:00 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 11,031 | $4.824 | $53,213 | 144,090 (Direct) | View |
| 2023-02-01 Sale | 2023-02-03 8:00 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 10,261 | $4.77 | $48,945 | 182,121 (Direct) | View |
| 2023-01-10 Sale | 2023-01-12 8:05 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 3,817 | $6.749 | $25,761 | 192,382 (Direct) | View |
| 2022-06-17 Sale | 2022-07-01 9:30 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 276,000 | $1.0911 | $301,140 | 2,562,003 (Direct) | View |
| 2022-04-04 Sale | 2022-04-22 8:31 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 121,641 | $1.7388 | $211,505 | 2,838,003 (Direct) | View |
| 2021-02-04 Sale | 2021-02-05 8:16 pm | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 118,790 | $3.4706 | $412,270 | 3,153,210 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-26 Gift | 2024-06-28 8:01 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 37,890 | $0 | 1,939,280 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-13 4:21 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Oliviero James F III Director | 30,000 | $0 | 57,828 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 9:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 1,660,000 | $0 | 2,001,780 (Direct) | View |
| 2024-02-28 Gift | 2024-03-01 8:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 9,056 | $0 | 341,780 (Direct) | View |
| 2024-02-01 Gift | 2024-02-02 8:10 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 12,950 | $0 | 356,730 (Direct) | View |
| 2023-02-24 Ownership | 2024-02-02 8:05 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 54,510 | $0 | 381,580 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 08:16 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Oliviero James F III Director | 18,000 | $0 | 27,828 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-04 8:30 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 250,000 | $0 | 394,090 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-03 8:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 15,000 | $0 | 144,090 (Direct) | View |
| 2022-09-26 Ownership | 2023-01-12 8:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 60,000 | $0 | 196,199 (Direct) | View |
| 2022-01-24 Tax Withholding | 2022-04-22 8:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 143,136 | $2.19 | 2,838,003 (Direct) | View |
| 2022-01-30 Tax Withholding | 2022-04-22 8:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 31,972 | $2.46 | 2,838,003 (Direct) | View |
| 2022-01-01 Tax Withholding | 2022-04-22 8:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 302,777 | $3.11 | 2,838,003 (Direct) | View |
| 2022-02-24 Tax Withholding | 2022-04-22 8:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 117,657 | $1.85 | 2,838,003 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-04-22 8:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 53,024 | $2.77 | 2,838,003 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:47 pm | 2023-04-01 2032-04-01 | Nuvectis Pharma Inc. | NVCT | Oliviero James F III Director | 15,000 | $0 | 15,000 (Direct) | View |
Ownership | 2022-02-08 08:28 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Oliviero James F III Director | 0 | $0 | 39,078 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 7:00 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 455,000 | $0 | 3,608,210 (Direct) | View |
| 2021-01-06 Option Award | 2021-01-08 4:31 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 539,000 | $0 | 3,272,000 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-25 7:01 pm | N/A N/A | Checkpoint Therapeutics Inc. | CKPT | Oliviero James F III CEO, President and Director | 598,000 | $0 | 2,733,000 (Direct) | View |